Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mark P. Roberto"'
Autor:
Jennifer L. S. Willoughby, Kelly George, Mark P. Roberto, Hang Gyeong Chin, Patrick Stoiber, Hyunjin Shin, Chandra Sekhar Pedamallu, Scott E. Schaus, Kevin Fitzgerald, Jagesh Shah, Ulla Hansen
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background The oncogene LSF (encoded by TFCP2) has been proposed as a novel therapeutic target for multiple cancers. LSF overexpression in patient tumors correlates with poor prognosis in particular for both hepatocellular carcinoma and colo
Externí odkaz:
https://doaj.org/article/78196f74ff6642ea90ac3be30f035d7e
Autor:
Dirk Homann, Arun Cumpelik, Mark P. Roberto, Sergio A. Lira, Farideh Ordikhani, David Dominguez-Sola, Gabriele Varano, Zhengxiang He, Yuan Hu, Peter S. Heeger, Dávid Héja
Publikováno v:
Nature immunology
Maturation of B cells within germinal centers (GCs) generates diversified B cell pools and high-affinity B cell antigen receptors (BCRs) for pathogen clearance. Increased receptor affinity is achieved by iterative cycles of T cell–dependent, affini
Autor:
Rosa Vinas-Castells, Alja Kozulic-Pirher, Tomás Aparicio, Sandra Casas Recasens, Mark P. Roberto, Rachel Sue, Francisco Martinez, Nuria López-Bigas, Jean Gautier, David Dominguez-Sola
Publikováno v:
Cancer Research. 82:1517-1517
Oncogene deregulation triggers replication stress, which can be detected in precancerous lesions and is a source of subsequent genomic instability in cancer. Studies on the mechanisms underlying DNA replication stress caused by frequently deregulated
Autor:
Antony B. Holmes, Mark P. Roberto, Laura Pasqualucci, David Scott, Rosa Vinas-Castells, Gabriele Varano, David Dominguez-Sola, Pedro Farinha, Rajesh Kumar
Publikováno v:
Immunity
The transcription factor forkhead box O1 (FOXO1), which instructs the dark zone program to direct germinal center (GC) polarity, is typically inactivated by phosphatidylinositol 3-kinase (PI3K) signals. Here, we investigated how FOXO1 mutations targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5e1201d803d4701893c68f89e65d00
https://hdl.handle.net/11392/2473129
https://hdl.handle.net/11392/2473129
Autor:
Jagesh V. Shah, Scott E. Schaus, Hyunjin Shin, Chandra Sekhar Pedamallu, Patrick Stoiber, Hang Gyeong Chin, Jennifer L.S. Willoughby, Mark P. Roberto, Kelly George, Ulla Hansen, Kevin Fitzgerald
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
BMC Cancer
BMC Cancer
Background The oncogene LSF (encoded by TFCP2) has been proposed as a novel therapeutic target for multiple cancers. LSF overexpression in patient tumors correlates with poor prognosis in particular for both hepatocellular carcinoma and colorectal ca
Autor:
Ephraim Kenigsberg, Joan Shang, Jovani Catalan, Tamar Plitt, Dan Fu Ruan, Katherine E. Lindblad, Jamie Redes, Francesca Cossarini, Zeynep H. Gümüş, Maria Casanova-Acebes, Julio A. Aguirre-Ghiso, Nina Bhardwaj, Robert M. Samstein, Venu Pothula, Uri Laserson, Matthew Lin, Erica Dalla, Jeremiah J. Faith, Manasi Agrawal, Alice O. Kamphorst, Ivan Reyes Torres, Luisanna Pia, Monica Centa, Jessica Tan, Brian D. Brown, Jonathan Chung, Graham J. Britton, Miriam Saffern, Assaf Magen, Matthew P. Spindler, Conor Gruber, Saurabh Mehandru, Amir Horowitz, Timothy O'Donnell, Florian Krammer, Jill Gregory, Gabrielle Lubitz, Pauline Hamon, Meriem Belabed, Matthew Brown, Emma Risson, Louise Malle, Emilie K. Grasset, Alfonso R. Sanchez-Paulete, Justine Noel, Zafar Mahmood, Daniel Lozano-Ojalvo, Mark P. Roberto, Julia Kodysh, Verena van der Heide, Evan Cody, Elliot Meritt, Chang Moon, Maria Suprun, Andrew Leader, Bérengère Salomé, Nicolas F. Fernandez, Dusan Bogunovic, Michelle Tran, Nicolas Vabret, Dirk Homann, Miyo Ota, Cansu Cimen Bozkus, Andrew Charap, Divya Jha, Konstantina Alexandropoulos, Etienne Humblin, Benjamin Greenbaum, Maria Kuksin, Gustavo Martinez-Delgado, Andrew K Chan, Myvizhi Esai Selvan, C. Matthias Wilk, Maria A. Curotto de Lafaille, Samarth Hegde, Alessandra Soares Schanoski, Joel Kim, Jaime Mateus-Tique, Alvaro Moreira, John A. Grout, Rachel Levantovsky, Natalie Vaninov, Peter S. Heeger, Mark Aleynick, Matthew D. Park, Judy H. Cho, Miriam Merad, Steven T. Chen
Publikováno v:
Immunity
The coronavirus disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an unprecedented effort from the scientific community to understand the biolo
Autor:
Shigeki Nakagawa, Yujin Hoshida, Daniela Sia, Pedro Molina-Sánchez, Veronica Miguela, Amaia Lujambio, Josep M. Llovet, Victoria Tovar, Mark P. Roberto, Marina Ruiz de Galarreta, Christie B. Nguyen, Julien Bollard, C Billie Bian, Anu Venkatesh
Publikováno v:
Gut
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Objective Advanced hepatocellular carcinoma (HCC) is a lethal malignancy with limited treatment options. Palbociclib, a well-tolerated and selective CDK4/6 inhibitor, has shown promising results in the treatment of retinoblastoma (RB1)-positive breas
Autor:
Pedro Farinha, David Dominguez-Sola, Antony B. Holmes, Mark P. Roberto, Rajesh Kumar, Rosa Vinas-Castells, David Scott, Gabriele Varano
Publikováno v:
Blood Cancer Discovery. 1:PO-40
The transcription factor FOXO1 directs germinal center (GC) polarity and supports affinity maturation by modulating immune activation programs in GC B cells. Recurrent somatic mutations targeting FOXO1 in GC-derived B-cell non-Hodgkin lymphomas (B-NH